INVA Innoviva PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: INVA
- PE Ratio
The current PE ratio of INVA cannot be calculated, as the latest EPS of -$0.95 is negative. The last PE ratio of Innoviva, recorded in December 2024, was 46.89.
INVA PE ratio history
The PE ratio of Innoviva has averaged 11.51 over the last nine years. Analyzing the last nine years, INVA's PE ratio reached its highest point in the Jun 2016 quarter at 61.94, when the price was $10.53 and the EPS was $0.17. The lowest point was recorded in the Sep 2022 quarter, when it reached 2.68 with a price of $11.61 and an EPS of $4.33.
Innoviva PE ratio by year
Maximum annual increase: 704.29% in 2024
Maximum annual decrease: -60.79% in 2018
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 46.89 | 704.29% | $17.35 | $0.37 |
| 2023 | 5.83 | 34.95% | $16.04 | $2.75 |
| 2022 | 4.32 | -18.8% | $13.25 | $3.07 |
| 2021 | 5.32 | -5.17% | $17.25 | $3.24 |
| 2020 | 5.61 | -38.62% | $12.39 | $2.21 |
| 2019 | 9.14 | 105.39% | $14.16 | $1.55 |
| 2018 | 4.45 | -60.79% | $17.45 | $3.92 |
| 2017 | 11.35 | -42.71% | $14.19 | $1.25 |
| 2016 | 19.81 | N/A | $10.7 | $0.54 |
| 2015 | N/A | N/A | $10.54 | -$0.16 |
| 2014 | N/A | N/A | $14.15 | -$1.5 |
| 2013 | N/A | N/A | $28.73 | -$1.67 |
| 2012 | N/A | N/A | $17.92 | -$0.2 |
| 2011 | N/A | N/A | $17.81 | -$1.41 |
| 2010 | N/A | N/A | $20.2 | -$1.16 |
Innoviva PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2025 | N/A | N/A | $18.13 | -$0.95 |
| Dec 2024 | 46.89 | 145.24% | $17.35 | $0.37 |
| Sep 2024 | 19.12 | 162.28% | $19.31 | $1.01 |
| Jun 2024 | 7.29 | 35% | $16.4 | $2.25 |
| Mar 2024 | 5.4 | -7.38% | $15.24 | $2.82 |
| Dec 2023 | 5.83 | -63.65% | $16.04 | $2.75 |
| Sep 2023 | 16.04 | 323.22% | $12.99 | $0.81 |
| Jun 2023 | 3.79 | 12.8% | $12.73 | $3.36 |
| Mar 2023 | 3.36 | -22.22% | $11.25 | $3.35 |
| Dec 2022 | 4.32 | 61.19% | $13.25 | $3.07 |
| Sep 2022 | 2.68 | -71.67% | $11.61 | $4.33 |
| Jun 2022 | 9.46 | 25.13% | $14.76 | $1.56 |
| Mar 2022 | 7.56 | 42.11% | $19.35 | $2.56 |
| Dec 2021 | 5.32 | 11.76% | $17.25 | $3.24 |
| Sep 2021 | 4.76 | -2.46% | $16.71 | $3.51 |
INVA average PE ratio chart
INVA PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| OPTN OptiNose Inc | N/A | $94.58M |
| OPK Opko Health Inc | N/A | $999.25M |
| ORGO Organogenesis Holdings Inc | N/A | $677.26M |
| INVA Innoviva Inc | N/A | $1.17B |
Frequently asked questions
What is Innoviva's PE ratio?
The current price to earnings ratio of INVA cannot be determined, as its EPS of -$0.95 is negative.
What is the 3-year average PE ratio for Innoviva (INVA)?
The 3-year average PE ratio for INVA stock is 11.29.
What is the 5-year average PE ratio for Innoviva (INVA)?
The 5-year average PE ratio for INVA stock is 8.85.
What is the highest PE ratio for INVA?
Over the last nine years, the quarterly PE ratio reached its highest level at 61.94 in the Jun 2016 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.